Cochrane Abstracts
Intravenous chemotherapy versus intra‐arterial chemotherapy for retinoblastoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Chemotherapy Versus Intra‐arterial Chemotherapy for Retinoblastoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440899/all/Intravenous_chemotherapy_versus_intra‐arterial_chemotherapy_for_retinoblastoma.
Intravenous chemotherapy versus intra‐arterial chemotherapy for retinoblastoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440899/all/Intravenous_chemotherapy_versus_intra‐arterial_chemotherapy_for_retinoblastoma. Accessed April 18, 2026.
Intravenous chemotherapy versus intra‐arterial chemotherapy for retinoblastoma. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440899/all/Intravenous_chemotherapy_versus_intra‐arterial_chemotherapy_for_retinoblastoma
Intravenous Chemotherapy Versus Intra‐arterial Chemotherapy for Retinoblastoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440899/all/Intravenous_chemotherapy_versus_intra‐arterial_chemotherapy_for_retinoblastoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous chemotherapy versus intra‐arterial chemotherapy for retinoblastoma
ID - 440899
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440899/all/Intravenous_chemotherapy_versus_intra‐arterial_chemotherapy_for_retinoblastoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
